Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas

APMIS

Volumn 108, Issue 3, 2000, Pages 195-200

  Park, Won Sang ^a   Oh, Ro Ra ^a   Kim, Young Sil ^a   Park, Jik Young ^a   Shin, Min Sun ^a   Lee, Hun Kyoung ^a   Lee, Sug Hyung ^a   Yoo, Nam Jin ^a   Lee, Jung Young ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Gastric cancer; Immunohistochemistry; MET: HGF SF; Mutation

Indexed keywords

PROTEIN TYROSINE KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CARCINOMA; TUMOR CELL;

EID: 0034015241     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2000.d01-44.x     Document Type: Article

References (27)

1. 1. Ministry of Health and Social Affairs. Five year's report for cancer registry program in the Republic of Korea. J Korean Cancer Assoc 1989;21:151-216.
2. 2. Powell SM, Cummings OW, Mullen JA, Asghar A, Fuga G, Piva P, et al. Characterization of the APC gene in sporadic gastric adenocarcinomas. Oncogene 1996;12:1953-9.
3. 3. Strickler JG, Zheng J, Shu Q, Burgart LJ, Albert SR, Shibata D. p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail. Cancer Res 1994;54:4750-5.
4. 4. Tahara E. Genetic alterations in human gastrointestinal cancers: the application to molecular diagnosis. Cancer 1995;75:1410-7.
5. 5. Comoglio PM. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. In: Goldberg ID, Rosen EM, editors. Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the C-MET receptor. Basel: Birkhäuser Verlag; 1993, 131-65.
6. 6. Weidner KM, Sachs M, Birchmeier W. The Met receptor tyrosine kinase transduces motility, proliferation and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol 1993;121:145-54.
7. 7. Di Rnzo M, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 1991;6:1997-2003.
8. 8. Ponzetto C, Giordano S, Abate ML, Huebner K, Croce CM, Vande Woude GF, et al. C-met is amplified but not mutated in a cell line with an activated MET tyrosine kinase. Oncogene 1991; 6:553-60.
9. 9. Liu C, Park M, Tsao MS. Overexpression of c-met protooncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. Oncogene 1992;7:181-5.
10. 10. Taniguchi K, Yonemura Y, Nojima N, Hirono Y, Fushida S, Fujimura T, et al. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor. Cancer 1998;82:2112-22.
11. 11. Shibamoto S, Hayakawa M, Hori T, Oku N, Miyazawa K, Kitamura N, et al. Hepatocyte growth factor and transforming growth factor-beta stimulate both cell growth and migration of human gastric adenocarcinoma cells. Cell Struct Funct 1992;17:185-70.
12. 12. Zhuang Z, Park WS, Pack S, Schmidt L, Vortmeyer AO, Pak E, et al. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nat Genet 1998;20:66-9.
13. 13. Park WS, Dong SM, Kim SY, Na EY, Shin MS, Pi JH, et al. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. Cancer Res 1999;59:307-10.
14. 14. Lauren P. The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma: an attempt at histoclinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
15. 15. Lee JY, Dong SM, Kim SY, Yoo NJ, Lee SH, Park WS. A simple, precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections. Virchows Arch 1998;433:305-9.
16. 16. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude GF. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA 1987;84:6379-83.
17. 17. Park M, Dean M, Cooper CS, Schmidt M, O'Brien SJ, Blair DG, et al. Mechanism of met oncogene activation. Cell 1986;45:895-904.
18. 18. Lin JC, Naujokas M, Zhu H, Nolet S, Park M. Intron-exon structure of the MET gene and cloning of an alternatively-spliced MET isoform reveals frequent exon-skipping of a single large internal exon. Oncogene 1998;16:833-42.
19. 19. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, Tahara E. Frequent amplification of the c-met gene in scirrhous type of stomach cancer. Biochem Biophys Res Commun 1992;189:227-32.
20. 20. Kuniyasu H, Yasui W, Kitadai Y, Tahara E. Aberrant expression of c-met mRNA in human gastric carcinomas. Int J Cancer 1993;55:72-5.
21. 21. Prat M, Narsimhan RP, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 1991;49:323-8.
22. 22. Rahimi N, Tremblay E, Mcadam L, Park M, Schwall R, Elliott B. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma. Cell Growth Differ 1996;7:268-70.
23. 23. Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, Vande Woude GF. The met proto-oncogene receptor and lumen formation. Science 1992;257:1258-61.
24. 24. Bellusci S, Moens G, Gaudino G, Comoglio P, Nakamura T, Thiery JP, Jouanneau J. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased turmo-rigenicity. Oncogene 1994;9:1091-9.
25. 25. Cortner J, Vande Woude GF, Kong S. The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis. In: Godberg ID, Rosen EM, editors. Epithelial-mesenchymal interactions in cancer. Basel Boston Berlin: Birkhäuser; 1995, 89-121.
26. 26. Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini PL, et al. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 1995;10:739-49.
27. 27. Kaji M, Yonemura Y, Harada S, Liu X, Terada I, Yamamoto H. Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene Therapy 1996;3:393-404.